[Pharmacology studies on the influencing of chondroitin sulfate decomposition in vitro].
D000632:Aminopyrine; D000893:Anti-Inflammatory Agents; D000983:Antipyrine; D001241:Aspirin; D055598:Chemical Phenomena; D002621:Chemistry; D002738:Chloroquine; D002807:Chondroitin; D003300:Copper; D003720:Densitometry; D005419:Flavonoids; D005439:Flufenamic Acid; D005944:Glucosamine; D006821:Hyaluronoglucosaminidase / Q000037:antagonists & inhibitors; D007501:Iron; D008012:Lidocaine; D008297:Male; D008314:Malonates; D008744:Methylamines; D010113:Oxyphenbutazone; D011239:Prednisolone; D012431:Rutin; D012965:Sodium Chloride; D012980:Sodium Salicylate; D013431:Sulfates; D013737:Testis / Q000201:enzymology; D014227:Triazines
D000893:Anti-Inflammatory Agents; D005419:Flavonoids; D008314:Malonates; D008744:Methylamines; D013431:Sulfates; D014227:Triazines; D000632:Aminopyrine; D012965:Sodium Chloride; D012431:Rutin; D005439:Flufenamic Acid; D003300:Copper; D002738:Chloroquine; D002807:Chondroitin; D008012:Lidocaine; D011239:Prednisolone; D007501:Iron; D006821:Hyaluronoglucosaminidase; D010113:Oxyphenbutazone; D005944:Glucosamine; D001241:Aspirin; D000983:Antipyrine; D012980:Sodium Salicylate
Pharmakologische Studien zur Beeinflussung des Chondroitinsulfat-Abbaus in vitro.